User:Bawolff/Edit COI Summary/15 per page (alphabetical)/15


Edit Request

edit

  • Subject Disclosure: I am Howard J. Buss, the subject of this article. I am requesting these edits to provide independent verification for the "Early life and education" and "Awards" sections to resolve the maintenance banner added in October 2025.
  • Background of request: This Wikipedia page about my work as a composer was severely trimmed on October 10, 2025 by one editor in particular. I visited the page versions prior to that date and see that all of the information was factual, just not properly sourced.
  • Below I will provide some of the links to references. At one point the lists of my compositions and recordings was severely pared. I see nothing wrong with what was posted when comparing what was there with other composer Wikipedia pages such as that about Erik Ewazen. I appreciate your help in fixing the issues.

Request: I ask that an editor integrate these citations into the relevant sections. Once verified, please remove the maintenance banner stating that the "section needs additional citations for verification." If you require additional references, I would be happy to provide them.

Thank you for your assistance in ensuring the accuracy of this page. ComposerBuss (talk) 20:59, 29 April 2026 (UTC)


edit

  • What I think should be changed (include citations):

*Financial problems (cont.)*

In 2005, the company restructured under a plan that transferred ownership to creditors, thereby discharging much of its debt. [1]

The Pension Benefit Guarantee Corporation assumed responsibility for Huffy's pension plan after its termination in 2005. [2]


Consolidating Repetitive Exhibition and Collection Lists

edit

Hugh O'Donnell here! I am trying to clarify the text representing me on wikipedia. I need to remove repetative information that I've seen in the the second and third paragraphs in the life and work section. I would like it to read thus:

Although exhibiting regularly in solo and group shows since 1975, O’Donnell gained international recognition after his inclusion in the 1980 exhibition British Art Now: An American Perspective at the Solomon R. Guggenheim Museum. He has since exhibited extensively throughout the United States, Japan, Europe, and the United Kingdom, including presentations at the Royal Academy of Arts, London; the XLII Venice Biennale, Italy; and the IV Medellin Biennale, Colombia. His work is held in numerous permanent museum collections internationally, including The Metropolitan Museum of Art; The Museum of Modern Art, New York; the Solomon R. Guggenheim Museum; the National Gallery of Art, Washington D.C.; the Hirshhorn Museum and Sculpture Garden; the Walker Art Center, Minneapolis; the Tate Gallery, London; the Victoria and Albert Museum; the Museum of Contemporary Art, Tokyo; the National Museum of Modern Art, Kyoto; the Yokohama Museum of Art; the Albright-Knox Art Gallery; and the Denver Art Museum. Hughartist (talk) 15:03, 8 July 2026 (UTC)


2013 promotional content tag

edit

Hello! I'm E, a representative for Humana. I saw that this article had a promotional tag on it that is over a decade old. Specifically, it mentions "removing promotional language and inappropriate external links"

I looked into the history and the tag seems to be pertaining to an old "Humana's Prescription Home Delivery" section with a link to the service both in the reference and in the External links section. You can see it here

That section and link have since been removed and editors will see the page overall has been substantially changed since the tag was added in 2013. Would an editor remove this tag? Because of my conflict of interest, I will not make direct changes to the article. Thanks! E Humana (talk) 20:43, 7 October 2025 (UTC)

I'm unclear why the tag was added. There's no edit summary nor corresponding talk page discussion.
Skimming the current references, it appears the article is heavily dependent upon press releases and similarly poor and promotional sources. Given this, the template still seems to fit, specifically, adding encyclopedic text written from a neutral point of view. --Hipal (talk) 21:34, 7 October 2025 (UTC)
The Promotional tag has to do with marketing-style or showboating language in the article, not the use of suboptimal sources. I have scanned the article for such and found nothing that is a particular problem that would require this tag, and have removed the tag. If anyone wants to add better citations, have at it. Stefen 𝕋ower HuddleHandiwerk 18:20, 18 February 2026 (UTC)
My understanding of the general consensus around the use of the tag is not consistent with your interpretation. I've added a third-party tag after skimming over the first 15 refs and finding many problems. --Hipal (talk) 20:01, 18 February 2026 (UTC)
My understanding of the general consensus is what I stated, having been a Wikipedian for nearly 22 years. The third-party tag is a reasonable tag. Just because citations are insufficient doesn't mean "promotion" is happening to the degree where we would have a concern that demands a Promotional tag. Stefen 𝕋ower HuddleHandiwerk 20:05, 18 February 2026 (UTC)
I'm glad we agree on the way forward. --Hipal (talk) 16:46, 19 February 2026 (UTC)


Edit request Oct 21

edit
Thanks Hipal I see what you mean! I did some research and found sourcing more in line with what Wikipedia requires. The draft can be found in my user space, a quick breakdown is as follows:
Let me know if you have any thoughts, thanks! E Humana (talk) 14:52, 21 October 2025 (UTC)
Thank you. That's a lot to review. Glancing over it, a lot of the references look to be press releases or the like. It will take some careful reviewing to go over them all. --Hipal (talk) 15:49, 21 October 2025 (UTC)
Thanks Hipal! Let me know if you have any questions. I know it is a lot so I am happy to provide clarity. E Humana (talk) 19:53, 3 November 2025 (UTC)
If you could identify any that might be press releases or something similar, that would help. --Hipal (talk) 20:08, 3 November 2025 (UTC)
Hipal, when I was looking for sources, I was avoiding press releases and stuck to items with bylines when possible.
That being said, I looked at these closer and have a few notes on them for you to consider
  • Sources #4, #5, #6 link the announcements but don't attribute the content to it.
  • Source #3 credits Bloomberg
  • Source #8 and #18 have a staff writer byline but does look like it could have content lifted from a PR, but no attribution to one
  • Source #13 uses a quote from a press release
  • Source #14 and #15 are from the Fortune 500 website (which appears to be standard practice Fortune rankings)
  • Source #16 and #17 are from the race's published results (which appears to be standard practice for this type of information)
  • Sources #1-2, #7, #9-12, all appear reliable to me
With the exception of #14-17, the articles all at least have a staff writer byline, showing some level of fact checking and editorial oversight.
Happy to continue the discussion! Let me know what you think, E Humana (talk) 14:20, 6 November 2025 (UTC)
Apologies for not getting back to this sooner. I'm afraid that I still have little time to put into this, nor do I expect that will change in the coming months.
Re PGA: Are there sources that can verify that it is ongoing? Without them, the statement fails verification.
Re Avality, mobileStorm, Enclara Healthcare, etc : Why are they important to Humana?
While we do need to make sure references are reliable, we also need to make sure they indicate that the information is WP:DUE and encyclopedic. --Hipal (talk) 19:07, 2 December 2025 (UTC)
Hipal Good questions!
Re PGA: That is a good point and you are right about the point in time, since there is sourcing to show more concrete dates. Here is a better proposal:
Re Avality, mobileStorm, Enclara Healthcare, etc: I was looking more at sourcing than considering WP:DUE. As for WP:ENCYCLOPEDIC, I do think acquisitions, subsidiaries, divisions etc. do have enough knowledge value to warrant inclusion.
Let me know if you have any other questions! I understand you're busy and this will take a closer eye, I will just check in intermittently like I have been to see if you had any new thoughts. Thanks, E Humana (talk) 22:05, 11 December 2025 (UTC)

Thanks for the reminder about this. Re PGA tour sponsor:

The Sports Business Journal ref appears to be a warmed-over press release, so I'm unsure how much to rely upon it.

Maybe just

Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.[1][2]

I'm unclear if the change in Humana's role in 2011 should be included as well. --Hipal (talk) 19:48, 7 January 2026 (UTC)

Hipal I think that language is good! Let me know if there are any other questions. E Humana (talk) 18:35, 13 January 2026 (UTC)
I've added it and removed the related content sourced to press releases. --Hipal (talk) 18:54, 13 January 2026 (UTC)
Hipal Thanks for the update! Did you have any thoughts or questions on the sourcing updates and fixes in the above initial request in the expand box? If it helps, I can break out a new request to remove what has been done already. Just let me know! E Humana (talk) 17:36, 27 January 2026 (UTC)
Yes, breaking out new request(s) would help. Maybe group together simple requests that you feel should be easy to review and straightforward to approve. --Hipal (talk) 17:51, 27 January 2026 (UTC)


Filtered request

edit

Per Hipal I have taken the previous request seen above and removed what has already been done so the outstanding items can be evaluated.

Let me know if there are any questions E Humana (talk) 22:59, 29 January 2026 (UTC)

@Hipal: This is now the oldest in progress request. Can you please respond or remove the under review tag? Czarking0 (talk) 19:28, 10 February 2026 (UTC)
I've changed the tag to partially implemented. I don't see my schedule opening up enough for continuing to work on this alone in a timely manner. --Hipal (talk) 17:04, 15 February 2026 (UTC)
I understand! I have added the edit request template. Thanks for the heads up! E Humana (talk) 18:51, 18 February 2026 (UTC)
Hello StefenTower, I wanted to tag you on this request because I saw above your concerns about citations for this article and updating the tag. This request is to update the citations with neutral and independent sources in order to overall improve the article. Since I have a conflict of interest as an employee of Humana, I cannot make these updates myself and an independent editor should review it instead. I thought you would find these sources I have presented useful if you continue to go throughout the article and improve it. Let me know if you have any questions! E Humana (talk) 17:14, 25 February 2026 (UTC)
That's quite a bit to go through. I may pick at it here and there as I work on other things the next few weeks. Thank you for the thorough request at any rate. Stefen 𝕋ower HuddleHandiwerk 00:58, 27 February 2026 (UTC)
Same here: May partake bit by bit…
Gobucks821 (talk) 15:56, 10 March 2026 (UTC)
A response has not yet been received for this question.

Reply 22-MAY-2026

edit

  Request closed for inactivity  

  • The above edit request has not received any responses over the past 3 weeks (22 days in total).
  • Discussion is often a key component to implementing edits, and requests may be adversely affected when they fail to garner input from either reviewing or requesting editors. In light of this — and as a safeguard — this request has been declined as needing more discussion.[1]
  • The COI editor is urged to revive stalled communications by making contact with local editors on those editor's own talk pages, and then by moving those discussions back to this talk page.
  • The COI editor may also wish to broadcast requests for edits at the talk pages of the WikiProjects which govern this article. Those projects are usually listed at the top of an article's talk page.

Regards,  Spintendo  07:24, 22 May 2026 (UTC)

References

  1. "Wikipedia:COI edit requests - Declined requests". Wikipedia. 22 April 2026. If your request is denied, analyze the discussion or the reason why it was declined and make the relevant changes to the request or follow the advice in the thread if any and if appropriate. You may be directed to seek consensus, which means that your request is probably unclear or needs more discussion.


Operations section addition

edit

After recent feedback, I wanted to present editors with a diff of all the changes I plan on suggesting to improve this page. If you'd like to leave notes on the whole thing, feel free to leave feedback on this post or the draft's Talk page.

For now, I wanted to start off small with a proposal to add an Operations section. This includes content about the company, including leadership, company size, and functions/subsidiaries.

Operations
Executive leadership includes Jim Rechtin (CEO),[1] Japan Mehta (chief information officer),[2] and Celeste Mellet (chief financial officer).[3] It is headquartered at the Humana Waterside and Clocktower in downtown Louisville, Kentucky.[4]

Humana is the second-biggest Medicare Advantage insurer in the United States, as of 2025.[5] It has both an insurance segment and pharmacy and primary care subsidiary called CenterWell.[6]

References

  1. Minemyer, Paige (14 May 2024). "Jim Rechtin to step into Humana CEO role on July 1". Fierce Healthcare. Retrieved 22 April 2026.
  2. Casolo, Elizabeth (3 Feb 2026). "Humana deepens Google Cloud ties with AI-powered Agent Assist". Becker's Payer Issue. Retrieved 22 April 2026.
  3. Minemyer, Paige (3 December 2024). "Humana CFO Susan Diamond to step down in January". Fierce Healthcare. Retrieved 21 April 2026.
  4. Evans, Olivia (5 June 2025). "Humana CEO talks about company leaving iconic downtown Louisville tower". USA TODAY. Retrieved 22 April 2026.
  5. Mathews, Anna Wilde; Weaver, Christopher (5 June 2025). "Humana to Back Curbs to Medicare Advantage Billing Practices". The Wall Street Journal. Retrieved 22 April 2026.
  6. Cite error: The named reference Evans 2023 was invoked but never defined (see the help page).

Let me know if there is any feedback. Thanks! E Humana (talk) 19:03, 4 June 2026 (UTC)


Edit Request Process

edit

Hi Editor,

Isaac here from WATATAWA Consulting and we support several clients such as IHH Healthcare with their external engagements.

I would like to make some edits to IHH Healthcare’s Wikipedia page with the latest publicly available information. Would you be able to advise how we can move forward with this please? I’ve read Wikipedia:Edit Requests and it mentioned to indicate my request on the talk page prior to using the Edit Request Template or the Edit Request Wizard.

I understand that there were some issues with the previous attempt to make modifications. I have rectified it and will be the only person making any edits for the IHH Healthcare page moving forward via this new account.

Many thanks and hope to hear from you soon.

Best Regards,

Isaac Isaac at WATATAWA Consulting (talk) 09:18, 1 August 2023 (UTC)

Present us what would you like to change and back up your claims with reliable sources (per WP:BURDEN). A09 (talk) 12:11, 1 August 2023 (UTC)
Hi A09,
As a start:
1) IHH's latest updated revenue for Q1 2023 is RM 5.1 billion as seen in their latest results press release here and on their website here.
2)For the second and third paragraph of the body, could we amend it to:
Its portfolio of healthcare brands includes Pantai, Gleneagles and Prince Court in IHH Malaysia; Mount Elizabeth, Gleneagles, and Parkway in IHH Singapore; Gleneagles and ParkwayHealth in IHH Greater China; Fortis and Gleneagles Global in IHH India; and Acibadem in Turkiye and Europe.
IHH's subsidiaries include Pantai Holdings, Parkway Holdings, ParkwayLife REIT and Fortis. It is also the majority shareholder of Acıbadem Healthcare Group, the largest Turkish private healthcare company.
Reasons for amending point 2:
- Continental Hospitals was divested in 2021 as seen here.
- The International Medical University was also divested in 2022 as seen here.
- IHH Healthcare's brands and subsidiaries can be found here.
Our amends are backed by publicly available resources as linked. Do let us know if these are good to go, please – we will share a couple more requested edits for your advise after.
Best regards,
Isaac Isaac at WATATAWA Consulting (talk) 03:46, 2 August 2023 (UTC)
Hi Editor,
Hope you are well.
May I check if this is the correct way to present the changes that I would like to make?
Do let me know if any amends need to be made in terms of the formatting and I'll be happy to make them soonest.
Hope to hear from you soon.
Best Regards,
Isaac Isaac at WATATAWA Consulting (talk) 03:16, 7 August 2023 (UTC)
Hey there and sorry for a late reply, but I've been busy in last days. Usual way of making an edit request is via {{edit COI}} (as you have conflict of interest this one is the most appropriate). I'll take a look into the request later. Thanks in advance, A09 (talk) 09:16, 7 August 2023 (UTC)
Revenue RM 4.3 billion (Q2 2021)
+
Revenue RM 5.1 billion (Q1 2023)
+
In recent years, IHH has expanded significantly in India.
Its portfolio of healthcare brands includes Pantai, Gleneagles and Prince Court in IHH Malaysia; Mount Elizabeth, Gleneagles, and Parkway in IHH Singapore; Gleneagles and ParkwayHealth in IHH Greater China; Fortis, Global and Continental in IHH India; and Acibadem in Turkey.
+
Its portfolio of healthcare brands includes Pantai, Gleneagles and Prince Court in IHH Malaysia; Mount Elizabeth, Gleneagles, and Parkway in IHH Singapore; Gleneagles and ParkwayHealth in IHH Greater China; Fortis and Gleneagles Global in IHH India; and Acibadem in Turkiye and Europe.
IHH's subsidiaries include Pantai Holdings, Parkway Holdings, ParkwayLife REIT and Fortis. HH also owns the International Medical University in Kuala Lumpur and is the majority shareholder of Acıbadem Healthcare Group, the largest Turkish private healthcare company. IHH owns 52.3%[3] of the Hyderabad-based private healthcare provider Continental Hospitals Limited in India.
+
IHH's subsidiaries include Pantai Holdings, Parkway Holdings, ParkwayLife REIT and Fortis. It is also the majority shareholder of Acıbadem Healthcare Group, the largest Turkish private healthcare company.
  • Reason for the change: Updating to the publicly available information
  • References supporting change:
- Continental Hospitals was divested in 2021 as seen here.
- The International Medical University was also divested in 2022 as seen here.
- IHH Healthcare's brands and subsidiaries can be found here.
Dear A09, let me know if this is okay. Followed the template as much as possible. Many thanks! Isaac at WATATAWA Consulting (talk) 22:42, 20 August 2023 (UTC)
Partly done The infobox figure has been updated, but because no reference was provided, a citation needed inline template was applied. The information concerning the medical university was deleted as requested. The other information asked to be added was not implemented because it was not clear which references provided applied to which statements proposed. Regards,  Spintendo  16:34, 21 August 2023 (UTC)
Many thanks for making the edits. I've tried to work the references into the copy as below - let me know if this is sufficient or if there is another way that I should move forward with this.
{{edit COI}}
Specific text to be added or removed:
Its portfolio of healthcare brands includes Pantai, Gleneagles and Prince Court in IHH Malaysia; Mount Elizabeth, Gleneagles, and Parkway in IHH Singapore; Gleneagles and ParkwayHealth in IHH Greater China; Fortis and Gleneagles Global in IHH India; and Acibadem in Turkiye and Europe.
IHH's subsidiaries include Pantai Holdings, Parkway Holdings, ParkwayLife REIT and Fortis. It is also the majority shareholder of Acıbadem Healthcare Group, the largest Turkish private healthcare company. (https://www.ihhhealthcare.com/about-us/our-global-network)
Reason for the change: Adding information about IHH's subsidiaries add the relevant citation.
References supporting change:
1) https://www.ihhhealthcare.com/about-us/our-global-network
{{edit COI}}
Specific text to be added or removed: (from the Info Box) RM 5.1 billion
Reason for the change: adding citations
References supporting change:
1) https://www.ihhhealthcare.com/investors/financial-information/financial-highlights Isaac at WATATAWA Consulting (talk) 06:41, 23 August 2023 (UTC)
Hi Editor,
Hope you are well. Understand that you might be busy or tied up with other commitments.
Just wanted to follow up with the above. Would you be able to advise if the above edits can be made?
Do let me know. Looking forward to hearing from you!
Cheers, Isaac at WATATAWA Consulting (talk) 23:11, 30 August 2023 (UTC)
Hi Editor,
Following up on this - We've had some new developments and was wondering if we could add on to the list of edits proposed. IHH Healthcare's Group CEO position has been filled by Dr Prem Kumar Nair, the former IHH Healthcare Singapore CEO. His position will take effect from 1st October 2023 as per the press release linked below.
Many thanks and hope to hear from you soon!
Best regards,
Isaac Isaac at WATATAWA Consulting (talk) 01:24, 11 September 2023 (UTC)


COI editing

edit

@Isaac at WATATAWA Consulting, please use {{Edit COI}} to request changes instead of updating the article directly yourself. Thanks. JASWE (talk) 10:16, 25 September 2023 (UTC)

Hi JASWE, I have been trying to use the Edit COI to request changes instead of updating the article directly in the other talk page section. Appreciate if you could take a look at the below and let me know if the edits are good to go. Otherwise, if you could let me know what is missing or what is required that will be much appreciated too. Many thanks.
- Isaac
Specific text to be added or removed: To add text as below between 1st and 2nd paragraphs.
In recent years, IHH has expanded significantly in India.
Its portfolio of healthcare brands includes Pantai, Gleneagles and Prince Court in IHH Malaysia; Mount Elizabeth, Gleneagles, and Parkway in IHH Singapore; Gleneagles and ParkwayHealth in IHH Greater China; Fortis and Gleneagles Global in IHH India; and Acibadem in Turkiye and Europe.
IHH's subsidiaries include Pantai Holdings, Parkway Holdings, ParkwayLife REIT and Fortis. It is also the majority shareholder of Acıbadem Healthcare Group, the largest Turkish private healthcare company.
Reason for the change: Adding in information based on the publicly available website.
References supporting change: https://www.ihhhealthcare.com/about-us/our-global-network > IHH's networks of hospitals and subsidiaries can be found here - it can be use to cite the entire section to be added above. Isaac at WATATAWA Consulting (talk) 03:11, 26 September 2023 (UTC)
@Isaac at WATATAWA Consulting I am leaving the request to other uninvolved editors and since the backlog is small, it should be attended to quickly. Also, do remove the tags so the template will be in use. [[User:Justanothersgwikieditor|JASWE]] ([[User talk:Justanothersgwikieditor|talk]]) 03:39, 27 September 2023 (UTC) :::{{not done for now}} It would be helpful if the WikiLinks for the subsidiary companies and portfolio brands were noted with your request. If these companies and brands are independently notable, they would have their own Wikipedia pages, which augers well for their inclusion in the article. Also, the reference provided is from the subject company itself. Wikipedia prefers references from reliable secondary sources. This preference for secondary sources could be sidestepped if the companies were independently notable. Please note which companies are independently notable in the space just after this reply message. When ready to proceed with your request, please alter the request template's answer parameter to read from {{para|ans|yes}} to {{para|ans|no}}. Regards, [[User:Spintendo|<span style="font-size:85%;color:#f00;border:3px solid red;border-radius:15px;"> <b>Spintendo</b> </span>]] 05:18, 27 September 2023 (UTC) ::::Hi Spintendo, ::::Thanks for getting back to us. Have noted on citing from Wiki links and I have found the following below. do let me know if this is what you meant. Many thanks! ::::[[Parkway Pantai]], [[Gleneagles Hospital]], https://www.wikidata.org/wiki/Q104247474, [[Mount Elizabeth Hospital]], [[Fortis Healthcare]], [[Acıbadem Healthcare Group]], [[User:Isaac at WATATAWA Consulting|Isaac at WATATAWA Consulting]] ([[User talk:Isaac at WATATAWA Consulting|talk]]) 07:40, 1 October 2023 (UTC) :::::[[User:Isaac at WATATAWA Consulting|@Isaac at WATATAWA Consulting]] Thank you for providing the WikiLinks to some of the companies mentioned in your proposal. As not all of the companies mentioned in your proposal have Wikilinks, the final step in your request would be to include those Wikilinks for the companies which have them in a new edit request proposal, taking care to delete the mentioning of those companies which are not Wikilinked. A reference should accompany your request, but as the remaining companies mentioned will now all be independently notable, that reference may originate from any primary source you like, including company press releases or from the company itself (such as a link to the company's website where the announcement has been made{{efn|It appears as if you've already provided that reference, thank you for that.}}). Please post that new edit request below this reply post at your earliest convenience,{{efn|Please also change the request template's answer parameter to read from {{para|ans|yes}} to {{para|ans|no}}.}} so that the reviewer may add the text to the article. Regards, [[User:Spintendo|<span style="font-size:85%;color:#f00;border:3px solid red;border-radius:15px;"> <b>Spintendo</b> </span>]] 17:51, 1 October 2023 (UTC) ::::::Hi editor - as instructed above, a new edit COI request has been made as below with third party links to supplement the above Wikilinks. Many thanks. ::::::+++ ::::::<nowiki>{{edit COI}}
Specific text to be added or removed:
N.A.
+
In recent years, IHH has expanded significantly in India.
+
Its portfolio of healthcare brands includes Pantai, Gleneagles and Prince Court in IHH Malaysia; Mount Elizabeth, Gleneagles, and Parkway in IHH Singapore; Gleneagles in Greater China; Fortis and Gleneagles Global in IHH India; and Acibadem in Turkiye and Europe.
+
IHH's subsidiaries include ParkwayLife REIT and Fortis. It is also the majority shareholder of Acıbadem Healthcare Group, the largest Turkish private healthcare company.
Reason for the change: Updating to the publicly available information
References supporting change:
- IHH Healthcare's brands and subsidiaries can be found here.
- Third party sources referencing IHH Healthcare and ParkwayLife REITS relationship: https://www.businesstimes.com.sg/property/parkway-life-reit-ihh-healthcare-extend-lease-agreements-20-years-s150m-capex-injection
- Third party sources referencing IHH Healthcare and Prince Court Medical Centre's relationship: https://www.healthcareitnews.com/news/asia/ihh-healthcare-acquires-malaysia-s-prince-court-medical-center-rm102b
Isaac at WATATAWA Consulting (talk) 23:20, 8 October 2023 (UTC)

Notes


Update to lead section – headquarters and company scale

edit

On behalf of IHH Healthcare, I would like to propose an update to the lead section of the article.

IHH Healthcare Berhad (MYX: 5225) is an international private healthcare group focused on upmarket health services. It is Asia's largest private healthcare group. It is headquartered in Kuala Lumpur and its geographical footprint crosses Malaysia, Singapore, Turkey, India, Greater China (including Hong Kong), other parts of Asia and Central and Eastern Europe. The group has over 70,000 employees across 80 hospitals in 10 countries. It is listed on Bursa Malaysia and the Singapore Exchange.
+
IHH Healthcare Berhad (MYX: 5225) is a multinational private healthcare group headquartered in Singapore and Kuala Lumpur, Malaysia. The group operates 190 healthcare facilities, including 89 hospitals, across 10 countries and has a workforce of 76,000 employees across Singapore, Malaysia, Türkiye, India, Greater China (including Hong Kong), and other regions of Asia and Europe. It is listed on Bursa Malaysia and the Singapore Exchange.

Reason for the change: To update the lead section with current information regarding IHH Healthcare's headquarters, geographical presence and company scale.

References supporting change:

Thank you for reviewing this request. Kelly at Mutant (talk) 11:25, 8 July 2026 (UTC)


Request to add Features section — COI disclosure

edit

I am disclosing a conflict of interest: I work at DigiDNA, the company that develops iMazing. Per Wikipedia's COI guidelines, I am not editing the article directly but am instead submitting this request for review.

I am proposing two changes to the iMazing article:

1. Addition of a new "Features" section covering seven topics: backup and data management, media and file transfer, messaging and personal data export, app management, security (Spyware Analyzer), iMazing Mini, and enterprise features (iMazing Configurator).

2. Removal of the existing "Description" section, whose content is fully absorbed by the new Features section. Keeping both would create redundancy and weaken the article's structure.

All claims in the proposed section are supported exclusively by independent third-party sources, including Macworld, 9to5Mac, iMore, MacStories, MacRumors, iDownloadBlog, MacTrast, and Amnesty International. No primary or official iMazing sources are used for factual claims. The tone is neutral and descriptive throughout.

The full proposed section with inline citations is available below for review. I welcome any corrections or adjustments before inclusion.

Thank you.


Edit request: rewrite article to address résumé-style tone

edit

Please replace the current article wikitext in full, from the opening line beginning

through the final category line , with the replacement wikitext below.

=Ian Macpherson, 3rd Baron Strathcarron=


Edit request from article subject

edit

I am the subject of this article. Please add the following entry to the "Media works" section:

  • Andrea Moda Formula: The Legend of the Formula One Team Too Bad to Be True. Histria Books, 2026. ISBN 978-1-59211-814-4.[3]

This is a routine bibliography addition, verified by the publisher's listing above. Thank you. Strathogram (talk) 08:48, 13 July 2026 (UTC)


Edit request: Add source for "25 years of independence" award 2016

edit

Please add a source for this entry in the Awards section: "2016 – Breastplate "25 years of independence of Uzbekistan" for contribution to the development of science and technology in the country."

Source: Presidential Decree of the Republic of Uzbekistan No. UP-4850 dated 26.08.2016 "On awarding in connection with the twenty-fifth anniversary of independence of the Republic of Uzbekistan".

This official document verifies the award. I have a COI and will not edit directly. Thank you. Abror Kosimov (talk) 09:31, 19 May 2026 (UTC)

Red X symbolN Rejected: None of those awards appear to be independently notable in Wikipedia.  Spintendo  00:48, 18 June 2026 (UTC)
Thank you for the feedback, Spintendo.
Understood regarding the awards. Could you advise —
should the Awards section be removed entirely, or
would you recommend keeping only awards with
independent media coverage?
I have a COI and will not edit directly. Abror Kosimov (talk) 10:44, 29 June 2026 (UTC)


Edit request: Remove two unsourced breastplate awards

edit

Specifically, please remove these exact lines from the Awards section:

  • 2016 – Breastplate "25 years of independence

of Uzbekistan" for contribution to the development of science and technology in the country. [citation needed]

  • 2021 – Breastplate "30 years of Independence

of Uzbekistan" for contribution to the development of science and technology in the country. [citation needed]

Replace with: nothing (delete these lines entirely).


Edit request: Add source for "Honoured Innovator" award 2021

edit

Please add a source for this entry in the Awards section: "2021 – State award of an "Honoured Innovator and Rationalizer" of the Republic of Uzbekistan"

Source: [https://president.uz/uz/lists/view/4569 Presidential Decree No. 4569 dated 25.08.2021]. President.uz. The decree lists: "Abdurakhmonov Ibrokhim Yulchievich - Minister of Innovative Development of the Republic of Uzbekistan" under the honorary title "Honoured Innovator and Rationalizer of the Republic of Uzbekistan".

I have a COI and will not edit directly. Thank you. Abror Kosimov (talk) 07:55, 6 July 2026 (UTC)


Edit request: Fix name and add source for 2010 award

edit

Please make the following change in the Awards section:

CURRENT TEXT:

  • 2010 – State award "Kukrak Nishoni".

[citation needed]

REPLACE WITH:

  • 2010 – "Uzbekiston belgisi" (Badge of Uzbekistan)

award by the Kamolot Youth Union of Uzbekistan. source

The current text has an incorrect award name. The correct name is "Uzbekiston belgisi" kokrak nishoni, confirmed by this independent source:

[https://ziyouz.uz/yangiliklar/professor-ibrohim-abdurahmonov-tadbirini-topish-vaqti-keldi/ Professor Ibrokhim Abdurakhmonov interview]. Ziyouz.uz. 23 February 2017.

The article explicitly states: "Uzbekiston belgisi kokrak nishoni (2010)".

I have a COI and will not edit directly. Thank you. Abror Kosimov (talk) 08:46, 6 July 2026 (UTC)


Updated "History" section

edit

I'm Erik and I work at Incyte. I'm excited to collaborate with you all! Due to my conflict of interest, I am here with a request.

I'd like to request the wholesale replacement of the current History section on this article, with my proposed version. Half the citations in the current section are press releases or non-reliable sources, and the section itself doesn't really tell the story of Incyte's company history; it bounces from 2025 to 2015 to 2020 to 2021. The current section only really highlights two milestones in Incyte's history, and lacks a ton of context that is included in reliable sourcing. This proposed version tells that history more completely, while also improving the sourcing throughout.

Replace

In June 2025, Incyte named Bill Meury president, CEO, and a member of the board of directors. He replaced Hervé Hoppenot, who retired after 11 years of service.[4]
In September 2015, the company announced it had gained exclusive development and commercial right pertaining to Jiangsu Hengrui Medicine Co., Ltd's anti-PD-1 monoclonal antibody, SHR-1210, in a deal worth $795+ million.[5]
In January 2020, Incyte signed a collaboration and license agreement for the global development and commercialization of tafasitamab with MorphoSys.[6] On March 3, 2020, the agreement received antitrust clearance and thus became effective.[7]
Incyte established a European headquarters in Morges, Switzerland, in 2021.[8]

References

with this proposed content:

Incyte Corporation was founded by Roy A. Whitfield on April 8, 1991, in Palo Alto, California, as a genomics company. It became a public company in 1993.[1][2] Subsequently, scientists and chemists were recruited from DuPont to work for Incyte.[1][2] Incyte moved its headquarters to Delaware, and acquired Maxia Pharmaceuticals in 2003.[3][4][5]
In November 2013, Incyte announced its relocation to new headquarters in Wilmington, Delaware, completing the move by the end of 2014.[6][7][8] Hervé Hoppenot became CEO in January 2014.[7]
In 2017, the company became part of the S&P 500 Index, which tracks the 500 most widely held U.S. stocks.[9]
In 2015, Incyte established its European headquarters in Geneva, Switzerland, and later moved this headquarters in 2021.[10][11][12] The company expanded its Delaware headquarters, including the addition of a major research and development facility, in 2022.[3] That same year, Incyte acquired Villaris Therapeutics, and Escient Pharmaceuticals in 2024.[13][14]
For 2025, the company reported $5.141 billion in revenue, $6.957 billion in assets and $1.286 billion in net income.[15][16] Incyte is publicly traded on the NASDAQ under the symbol INCY.[2] Incyte now operates out of North America, Asia, and Europe.[17] Bill Meury became CEO in 2025.[18] Meury replaced Hoppenot, who retired after 11 years in the position.[7][18]

References

  1. 1 2 Milford, Maureen (November 21, 2014). "Incyte takes over reimagined Wanamaker building". Delaware Online. Retrieved December 12, 2025.
  2. 1 2 3 "Incyte". Forbes Magazine. 2025. Retrieved December 17, 2025.
  3. 1 2 Owens, Jacob (April 4, 2022). "Incyte opens new R&D lab in Wilmington". Delaware Business Times. Retrieved December 12, 2025.
  4. Baker, Karl (August 5, 2020). "Incyte progresses on COVID-19 treatment. Other big Delaware companies slog through tough economy". Delaware Online. Retrieved December 12, 2025.
  5. UNITED STATES SECURITIES AND EXCHANGE COMMISSION (2002). "QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934". SECURITIES AND EXCHANGE COMMISSION. Retrieved December 17, 2025.
  6. Malcolm, Wade (November 17, 2013). "Incyte to lease former Wanamaker building near Wilmington". Delaware Online. Retrieved December 12, 2025.
  7. 1 2 3 Anne Natoli, Cori (January 16, 2014). "Rising Incyte Corp. welcomes new CEO". Delaware Online. Retrieved December 12, 2025.
  8. Goss, Scott (March 3, 2015). "Incyte wins Delaware Bio company of the year honor, again". Delaware Online. Retrieved December 12, 2025.
  9. Mordock, Jeff (February 28, 2017). "Incyte joins prestigious Standard & Poor's 500 index". Delaware Online. Retrieved December 12, 2025.
  10. "Incyte to establish European headquarters in Geneva". 15 July 2020. Retrieved 12 September 2021. New facility to serve as European base for Incyte's drug development operations, and provides efficient access to key clinical trial experts and institutions.
  11. "Prof. Jocelyne Bloch and Prof. Grégoire Courtine receive the BioAlps Academia Award, and Incyte the BioAlps Industry Award". Bio Alps. November 25, 2022. Retrieved May 4, 2026.
  12. Wilson, Xerxes (July 31, 2015). "Incyte considering 400 job expansion near Wilmington". Delaware Online. Retrieved May 4, 2026.
  13. George, John (October 3, 2022). "Incyte to acquire North Carolina drug developer in deal valued at up to $1.36 billion". Philadelphia Business Journal. Retrieved December 17, 2025.
  14. Tabeling, Katie (June 3, 2024). "Incyte closes $750M deal for Escient Pharmaceuticals". Delaware Business Times. Retrieved December 17, 2025.
  15. "Incyte Corp. 2025 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. February 10, 2026.
  16. Incyte (February 10, 2026). "Incyte Reports Fourth Quarter and Full Year 2025 Financial Results". Incyte. Archived from the original on March 31, 2026. Retrieved March 31, 2026.
  17. Tabeling, Katie (October 23, 2024). "Incyte celebrated at du Pont Freedom Award reception". Delaware Business Times. Archived from the original on May 22, 2025. Retrieved December 17, 2025.
  18. 1 2 Tabeling, Katie (June 30, 2025). "Meury named Incyte CEO as Hoppenot departs". Delaware Business Times. Archived from the original on March 31, 2026. Retrieved March 31, 2026.

Let me know if anyone has questions here, and thanks INCY Erik (talk) 15:43, 8 June 2026 (UTC)


Article Lead Request

edit

Hello there,

I am acting on behalf of Informa and have some suggested changes to the lead.

What are my changes: The current first sentence of the lead does not accurately reflect what Informa does, so I have suggested a more accurate version.

In addition, can the introduction feature the operating divisions rather than examples of the notable brands owned by Informa?

This would help readers better understand the structure of the company - while the brands are notable, they don't illustrate what Informa does as a company. Listing the divisions also more accurately indicates the nature of the relationship between Informa's divisions and brands - Taylor & Francis for example is its own division which CRC Press and Routledge both sit within, but the current phrasing implies they sit alongside each other.

I plan to suggest some more content in the body of the article to better cover what each division does and use notable examples of brands within each to clarify this, but for this request I'm focusing on the introduction.

Finally, can the number of employees be updated to 14,000 (and the relevant figure corrected within the infobox)?

How it would appear:

Thanks in advance! HisNamesJim (talk) 14:56, 2 June 2025 (UTC)

Not done: A majority of the requested changes are currently written in a promotional tone. Please review WP:Neutral point of view and ensure you follow this before submitting any edit requests. Valorrr (lets chat) 01:13, 10 June 2025 (UTC)
Thank you @Valorrr for your feedback. Would you please mind indicating the language you feel in my request which is written in a promotional tone? HisNamesJim (talk) 09:50, 10 June 2025 (UTC)
One of the world's largest business events' organisers, along with some others. Valorrr (lets chat) 13:45, 10 June 2025 (UTC)
Hi @Valorrr. I understand that that could seem promotional but I disagree in cases where it is an objective statement.
Objectively, Informa is one of the world's largest companies in the organisation of business events' - this is supported by the Times article where it says: "Informa, formed in 1998 via the merger of IBC Group and Lloyd’s of London Press, is the largest organiser of trade shows in the world."
Other Wikipedia articles where the subject is the largest within their specific industry will also use "largest" within the article lead as a basic introduction to the subject i.e. airlines (American Airlines) - "largest airline in the world in terms of passengers carried and daily flights", banking (Goldman Sachs) - "second-largest investment bank in the world by revenue".
I appreciate I do have a COI so would you mind reopening the request so we could get a second opinion? I see that Pac Veten and Dormskirk have recently been active with updates to the article - would either of you have an opinion on my suggestions?
HisNamesJim (talk) 16:40, 11 June 2025 (UTC)
Sorry but "One of the world's largest business events' organisers, along with some others" sounds promotional to me. Dormskirk (talk) 16:45, 11 June 2025 (UTC)
Very, and we need NPOV. Valorrr (lets chat) 16:47, 11 June 2025 (UTC)
One of the world's largest business events' organisers
That was the text, but I said "among some others" to state there is some more. Valorrr (lets chat) 16:48, 11 June 2025 (UTC)
The tone sounds promotional to me also. Is there a way to quantify the statement for neutrality? For example, "Informa has x% of the global market for trade shows" or "Informa is among the top Y international vendors for trade shows"? Pac Veten (talk) 16:54, 11 June 2025 (UTC)
Or better, "Informa is among the top Y international vendors for trade shows (by revenue)." Pac Veten (talk) 17:06, 11 June 2025 (UTC)
Thank you Valorrr, Dormskirk and Pac Veten for your feedback. Very helpful for someone new to Wikipedia.
Pac Veten, as you have suggested, could the phrasing be altered to:
"Informa is the world's largest exhibition organizer by revenue..." as supported by these Exhibition News and Trade Shows New Network articles.
Additionally, what about other parts of the request? Are the changes suggested acceptable or does the language have to be adjusted?
1. Changes to the "lead" sentence to better reflect what Informa does.
2. Changing the last sentence to feature the operating divisions of Informa rather than examples of the notable brands owned by Informa.
Listing the divisions more accurately indicates the nature of the relationship between Informa's divisions and brands - Taylor & Francis for example is its own division which CRC Press and Routledge are brands within, but the current phrasing implies they sit alongside each other.
3. Updating the number of employees to 14,000.
Thanks again for your guidance. HisNamesJim (talk) 11:08, 12 June 2025 (UTC)
For what it's worth, I found the original lead sentence (with "business intelligence") more concrete and descriptive. The proposed new sentence may fit better with a corporate mission statement, but the context seems different here. Perhaps it would work to add an explicit sentence for the mission statement?
Similarly, the original list of brands (including CRC) seems helpful and evocative, while the list of divisions lacks flavor for a general audience, somehow. Why not include both--keep the original content, and then add a new description of Informa's operating divisions separately? Each list would provide a different kind of useful information. Pac Veten (talk) 16:28, 12 June 2025 (UTC)
Partly done: See comments. CNMall41 (talk) 21:22, 11 September 2025 (UTC)


Article Lead Request 2

edit

Hello there,

Following the feedback received from Pac Veten, I have reposted my request to change the article lead to make it clearer for interested editors.

  • Would it be possible to add phrasing to the second paragraph of the introduction which indicates Informa is the world's largest exhibition organizer by revenue, one of the reasons why the company is notable within its industry.
  • Can I suggest a sentence outlining the operating divisions of the company. This would make the introduction a better summary of the company and help clarify the relationship between Informa's divisions and brands.
  • Can the introduction be updated to reflect Informa's current business operations, specifically as follows:
  • By using the term "UK-founded" rather than "British", and "Multinational events" to clarify that the company hosts functions globally, not only domestically.
  • Informa no longer offers "business intelligence" services while "digital products", "specialist media" and "academic publishing business" represent the company's current operations more accurately. Informa, for example, is only involved with "academic publishing" rather than "publishing" generally through its Taylor & Francis division.
  • Finally, can the number of employees be updated to 14,000 (and the relevant figure corrected within the infobox).

How it would appear:

Thank you again for considering my request! HisNamesJim (talk) 14:58, 13 June 2025 (UTC)

This draft looks more neutral, to my eye, but some additional changes would be helpful:
- Where the company was founded is less important than what it does; the company is something like a conglomerate; and bold font is needed only for the company name. So I would suggest something like this for the first sentence, pending further changes: "Informa plc is a multinational conglomerate that is active in the areas of events, digital products, specialist media and academic publishing; the company was founded in the UK."
- The terms "digital products" and "specialist media" do not refer to concrete industries or fields that would be familiar to most readers. What are possible substitutes for these terms, which would be more widely known?
- Do the terms "events" and "exhibitions" refer to the same things? If so, it may be helpful to use a consistent term.
- Where are Informa's major offices located? For example, would "in the London and Boston areas" be sufficient to give a general idea?
- How many brands does Informa have? The word "numerous" implies between 8 and dozens . . .
- What does each Informa division do, in a few words each?
Hopefully these are useful comments, if detailed. Pac Veten (talk) 18:06, 13 June 2025 (UTC)
Similarly, if the 14,000 employees are located mainly in the US and the UK, it would be useful to include that clarification. Pac Veten (talk) 18:21, 13 June 2025 (UTC)
Hi @Pac Veten. Sorry for taking a while to get back to you.
I very much appreciate your detailed comments, which I've responded to in turn below. Just to clarify, I use bold to indicate my changes which I should have made clearer to you so apologies for any confusion!
1. I agree with your adjusted lead sentence. I suggest using the alternate term digital goods instead of "digital products" and "niche media" instead of "specialist media". Similar to my point regarding the alteration from "publishing" to "academic publishing", I feel it is important to readers to clarify that Informa does not publish mainstream media.
2. Events and exhibitions from my understanding are different, so it would be better to specify given their relevance here. Events are broader while exhibitions are more focused and subject-specific; for example the wider event of Cannes Film Festival will host exhibitions within the wider event itself.
3. For the lead at least, I do not see the value in adding where the company's major offices are located and it probably approaches WP:DIRECTORY territory, but others may disagree.
4. Informa does indeed have dozens of brands, too many to comprehensively list and this may fluctuate over time as well (I would like to tackle the brands section in a future request so it isn't too unwieldy), and this is why I'm keen to include the Divisions. I would not object to the beginning of this sentence being altered to read, "Some of Informa's most notable brands include..."
5. I am currently in the process of drafting changes to the "Operations" section which it would be great if you would like to offer your feedback on once I have submitted it! This will include an explanation of the five divisions - it might be appropriate to include this in the lead as well but in any case we can decide that once this first conversation is concluded to keep the Talk page organised.
6. I cannot find any independent reliable third-party references which include the employee split and would rather leave it out as this will continually change.
Look forward to hearing your feedback and thank you! HisNamesJim (talk) 16:55, 19 June 2025 (UTC)
Hi @HisNamesJim. I appreciate your latest thoughts--my comments are below.
1. The phrase "digital goods" is not standard for a general audience, so I think that it's still important to find common words to describe Informa's services. Such phrasing should be independent of any marketing strategy.
2. OK
3. Most Wikipedia articles about important companies indicate where their major offices are located. This information should be included for Informa as well.
4. It would be appropriate to replace the promotional word "numerous" with an approximate quantification of the number of brands that Informa owns. On the basis of your comments above, perhaps that would be "approximately fifty" in this case?
5. There are two options around treating divisions in the lead section. The first option is to attach a couple of words to each division as description; the second option is to remove the divisions from the lead section entirely, deferring this material for a later section, as you proposed. The current division listing in the lead section is opaque and does not add any value for a reader.
6. OK--item 3 above may be sufficient to substitute for item 6 here.
Hopefully these comments are useful in moving towards the next iteration. Pac Veten (talk) 18:26, 19 June 2025 (UTC)


Article Lead Request

edit

Hi there. Following helpful feedback from editors, I would like to repost a request to change the article lead.

  • Can the introduction be updated to reflect Informa's current business operations, specifically as follows:
  • By using the term "UK-founded" rather than "British", and "Multinational events" to clarify that the company hosts functions globally, not only domestically.
  • The phrasing "based in London" changed to "headquartered in London" so it is clearer that Informa has offices in other locations.
  • Informa no longer offers "business intelligence" services while "business-to-business digital services and media" and "academic publishing business" represent the company's current operations more accurately. Informa, for example, is only involved with "academic publishing" rather than "publishing" generally through its Taylor & Francis division, while its digital services and media products are focused on the business-to-business sector.
  • May the final sentence be updated by:
  • Changing "numerous" in regards to the amount of brands to "hundreds" so that there is an approximate quantification.
  • Adding several more notable brands (highlighted in bold) with Wikilinks to their relevant articles.
  • Finally, can the number of employees be updated to 14,000 (and the relevant figure corrected within the infobox).

How it would appear:

Thank you! HisNamesJim (talk) 10:25, 29 July 2025 (UTC)

@HisNamesJim:, responding to these requests individually since it is more than a single request. Give me time to sum everything up. Not everything is responded to in the order in which you requested.
1. 12,000 -> 14,000, this was implemented based on the primary source. --CNMall41 (talk) 21:09, 11 September 2025 (UTC)
2. British -> U.K. founded , not done. The first sentence of the MOS:LEAD describes where the company is located, not necessarily where it operates. See Facebook for example ("American social media and social networking service owned by the American technology conglomerate Meta"). --CNMall41 (talk) 21:14, 11 September 2025 (UTC)
3. based in -> headquarters, this was updated. --CNMall41 (talk) 21:15, 11 September 2025 (UTC)
4. numerous -> hundreds, not done. The lead needs to be a summary of the body. While the body lists many of the brands, it would be WP:OR to say "hundreds" unless there is a sentence in the "Brands" section which says "hundreds." That sentence would also need to be supported by a reliable source. I was going to do that change in order to change the lead, but I cannot find a reliable secondary source that says "hundreds." --CNMall41 (talk) 21:17, 11 September 2025 (UTC)
5. service types - not done. Again, the lead needs to be a summary of the body and currently what is written should not be there unless reliably sourced. If you have a good secondary source that shows what they currently offer, ping me here and I can add a sentence to the operations section and then change the lead to reflect your request. --CNMall41 (talk) 21:19, 11 September 2025 (UTC)
6. additional brands - not done. There are currently six which I feel is already too many for a summary based on the rule of three. You are asking that to be increased to 10 which is way too many in my opinion. --CNMall41 (talk) 21:21, 11 September 2025 (UTC)
Hi again. Thanks much for the update and for incorporating the previous feedback. This version looks significantly more informative and neutral—so I'd suggest that only two tasks remain. The first task is to subdivide the long list of brands according to the general categories provided above to describe the overall business. The second task is to copy edit the resulting full text. Since I belong to the Guild of Copy Editors, it would be natural for me to take on the second task. Would you mind taking on the first task? Pac Veten (talk) 23:56, 11 September 2025 (UTC)
Thanks for getting back to me @Pac Veten, and for all of your previous feedback. For now, I think I am going with CNMall41's suggestion that I focus on requesting changes to the main article body before returning back to the lead. HisNamesJim (talk) 11:56, 12 September 2025 (UTC)
Since the most recent proposed text above is the outcome of this long group discussion (to date), how should it be inserted as the article lead now - would you like to take care of that, or would you prefer me to handle it? Pac Veten (talk) 14:43, 12 September 2025 (UTC)
Long discussion is not necessary consensus. As stated above, the lead is a summary of the body. The question should be what, if anything, should be placed into the body. The lead can then be discussed after. It's a cart before the horse issue to build the lead without having the information in the body. --CNMall41 (talk) 18:08, 13 September 2025 (UTC)
Thank you @CNMall41 for your thorough feedback! I agree with the points raised. My next request is going to focus on the "Operations" section and suggest language which clarifies what the different divisions of the company do.
Would you also please update the approximate number of employees within the lead so that it matches the infobox. Thank you! HisNamesJim (talk) 11:52, 12 September 2025 (UTC)
I will. However, I am not sure it is even suitable for the lead so would not object if another editor removed. --CNMall41 (talk) 18:08, 13 September 2025 (UTC)
Yes, the total number of employees in a corporation is very appropriate for a lead section. Pac Veten (talk) 18:36, 13 September 2025 (UTC)


Operations Request

edit

Thank you @CNMall41 and @Pac Veten for offering your feedback.

As mentioned in my last request, I would like to put forwards some language and updates within the "Operations" section which clarifies the different divisions within Informa.

I hope this will then be reflected within the lead to better summarise the company's operations.

How it would appear:

Thank you again for reviewing! HisNamesJim (talk) 11:36, 17 September 2025 (UTC)

Thanks for the update. Here's my feedback:
- The new content looks OK overall. Please remove the word "led"—it may have a marketing connotation, but it unfortunately won't be meaningful to the average reader.
- Please indicate Informa's revenue breakdown by region and division, per Informa's 2024 annual report. This material should be easy to write up.
- In the lead section, please summarize or quote Informa's mission statement. This information helps to characterize the corporation for a new reader.
On reflection, the proposed article changes appear to have a larger problem, which will need addressing. Significant portions of the proposed new text (for lead and operations) appear to be taken directly from Informa's 2024 annual report. For compliance with Wikipedia's guidelines on plagiarism, I would suggest reviewing those guidelines and then adjusting the new text appropriately. Possible solutions include paraphrase and quotation, and inline citation in any case. These guidelines are available at WP:PLAG. Pac Veten (talk) 14:41, 17 September 2025 (UTC)
@Pac Veten:, I am going to dissent here. Why would it be appropriate to break down the company's revenue by region according to its annual report? Or, to include its mission statement? Are either of these worthy of inclusion? This seems to be the opposite of neutral tone. --CNMall41 (talk) 16:52, 17 September 2025 (UTC)
First, it's useful to repeat the previous feedback that's not covered by the most recent post. The second bullet below is particularly important, in light of the conflict-of-interest considerations that prompted this talk thread.
- The new content looks OK overall. Please remove the word "led"—it may have a marketing connotation, but it unfortunately won't be meaningful to the average reader.
- On reflection, the proposed article changes appear to have a larger problem, which will need addressing. Significant portions of the proposed new text (for lead and operations) appear to be taken directly from Informa's 2024 annual report. For compliance with Wikipedia's guidelines on plagiarism, I would suggest reviewing those guidelines and then adjusting the new text appropriately. Possible solutions include paraphrase and quotation, and inline citation in any case. These guidelines are available at WP:PLAG.
Second, here's the previous feedback that's covered by the most recent post:
- Please indicate Informa's revenue breakdown by region and division, per Informa's 2024 annual report. This material should be easy to write up.
- In the lead section, please summarize or quote Informa's mission statement. This information helps to characterize the corporation for a new reader.
The preceding two bullets are simply topics of general interest, which make them appropriate for Wikipedia readers. I agree that if the article were long, and length considerations prompted a consideration of triage, we might want to consider which topics to exclude. Since the article is so short (so far), it makes sense to amplify the content, to give a richer perspective on the corporation.
On this subject, including an explicit mission statement is actually a way to amplify neutrality, by indicating the corporation's goals and point of view. Newspapers often do something similar, as a way to increase trust with readers. So it's a great point that you raised, and hopefully it gives us an opportunity to build this trust with Wikipedia readers. Pac Veten (talk) 18:13, 17 September 2025 (UTC)
It is not about trust necessarily. It is about writing something from a WP:NPOV. Wikipedia is not a WP:SOAPBOX for the company to reiterate its financials. Think WP:READERSFIRST. No one is coming to Wikipedia to get that information. At this point, there would need to be consensus to implement those suggestions as I do not believe they adhere to the points I stated above. --CNMall41 (talk) 18:47, 17 September 2025 (UTC)
In the previous sections, there was discussion about promotional tone. Maybe ping those editors to see if they would be willing to opine.--CNMall41 (talk) 18:49, 17 September 2025 (UTC)
First, it's useful to repeat the previous feedback that's not covered by the most recent post. The second bullet below is particularly important, in light of the conflict-of-interest considerations that prompted this talk thread.
- The new content looks OK overall. Please remove the word "led"—it may have a marketing connotation, but it unfortunately won't be meaningful to the average reader.
- On reflection, the proposed article changes appear to have a larger problem, which will need addressing. Significant portions of the proposed new text (for lead and operations) appear to be taken directly from Informa's 2024 annual report. For compliance with Wikipedia's guidelines on plagiarism, I would suggest reviewing those guidelines and then adjusting the new text appropriately. Possible solutions include paraphrase and quotation, and inline citation in any case. These guidelines are available at WP:PLAG.
Second, here are some comments about the most recent post:
- A company's financials are not promotional - typically the opposite, more an objective measure. Were you envisioning a soapbox of some sort for this article?
- Given the large, international audience for Wikipedia, any claims about "no one" being interested in information are likely to be disproven quickly. This is actually an excellent reason for including more information in an article, rather than less (up to the point of saturation, as previously mentioned).
- Finally, if the corporate contributor in a conflict-of-interest situation is requesting the article's discussion to follow the corporation's guidance, this seems problematic. Broad inclusion of community interest seems better, per Wikipedia's guidelines and norms. This observation would suggest continuing to expand the article's content (up to the point of saturation, as previously mentioned). Pac Veten (talk) 19:40, 17 September 2025 (UTC)
If this discussion is unable to resolve the conflict of interest that was flagged, would it be best to end the proposal process for now? Input from editors with significant experience on Wikipedia may be particularly valuable here. Pac Veten (talk) 19:42, 17 September 2025 (UTC)
I'm getting a bit confused. I have no interest in pushing the revenue and mission statement points suggested here.
This request is focused on introducing descriptions within the "Operations" section, where the divisions are already listed, but not explained. This action is not intended to "follow the corporation's guidance", just to indicate an accurate definition.
This is because, at the moment, there is no explanation of the divisions, just the names and a long list of brands with nothing to indicate what groups them.
I'm happy to remove the "led" wording from the definitions - it just means that the word before is the main focus of the event, if that helps in finding an alternative.
As we are getting away from the original request, I agree it would be great if an experienced editor could offer their feedback - maybe one who has edited the article before in the past year or so such as Dormskirk, VulcanSphere, or Shortride. HisNamesJim (talk) 14:54, 18 September 2025 (UTC)
Thanks for the ping. I think the article looks good as it is. It lists the divisions in the operations section and then splits the brands by division in the brands section. Just my opinion. Dormskirk (talk) 15:12, 18 September 2025 (UTC)
I agree with Dormskirk's view, thanks for the ping. Vulcan❯❯❯Sphere! 15:27, 18 September 2025 (UTC)
It's useful to repeat the previous feedback that's not covered by the most recent post. The second bullet below is particularly important, in light of the conflict-of-interest considerations that prompted this talk thread.
- On reflection, the proposed article changes appear to have a larger problem, which will need addressing. Significant portions of the proposed new text (for lead and operations) appear to be taken directly from Informa's 2024 annual report. For compliance with Wikipedia's guidelines on plagiarism, I would suggest reviewing those guidelines and then adjusting the new text appropriately. Possible solutions include paraphrase and quotation, and inline citation in any case. These guidelines are available at WP:PLAG.
Pac Veten (talk) 16:40, 18 September 2025 (UTC)
It is actually not useful at this point to "repeat the previous feedback" as you have done so quite a few times. Those involved in the discussion are well aware. As far as "it would be great if an experienced editor could offer their feedback" I guess I should not have assumed that I was an experienced editor in the company-related article space. I am also puzzled by "would it be best to end the proposal process for now" as that would be the OP's decision if they want to end the discussion. I'm sorry to sound so blunt but you seem to be moving the topic of discussion. If you are advocating for the introductory or advertorial material, you will need to start a thread to get consensus. --CNMall41 (talk) 16:52, 18 September 2025 (UTC)
Can you please point me to the reply that addressed plagiarism from the company's annual report? I might have missed that post. Pac Veten (talk) 16:57, 18 September 2025 (UTC)
Not sure what you are referring to. I did not say anything about plagiarism. --CNMall41 (talk) 17:54, 18 September 2025 (UTC)
Plagiarism has been mentioned twice in the comments above. It will be good to get the group's thoughts on that. Pac Veten (talk) 21:38, 18 September 2025 (UTC)
It has been mentioned four times. By you. It is not relevant. --CNMall41 (talk) 18:04, 22 September 2025 (UTC)
Is it the group's opinion that copying text from a company's annual report does not raise any questions around WP:PLAG? Pac Veten (talk) 21:12, 22 September 2025 (UTC)
Thanks all for your feedback. It appears a consensus cannot be agreed on whether the descriptions of the divisions should be added so I will now close the request. HisNamesJim (talk) 10:57, 19 September 2025 (UTC)


History Section Request

edit

Hi there.

I would like to suggest several changes to the "History" section, which is currently difficult to navigate, gives undue weight to certain historic events, while omitting several more recent notable happenings.

To begin with, to improve navigability for readers, may I suggest a timeframe which will divide the section into two.

This would consist of two sub-headings, one between 1998 (when Informa was formed) to 2013 and one from 2014 (coinciding with when Stephen Carter began his role as CEO) to the present.

How it would appear:

Thank you all for looking into my request! HisNamesJim (talk) 15:46, 7 October 2025 (UTC)

Done. Dormskirk (talk) 15:56, 7 October 2025 (UTC)


History Section Request 2

edit

Really appreciate it Dormskirk for implementing the sub-headings!

My next request for the "History" section focuses on revising the second half of the "1998 to 2013" sub-section.

Currently undue weight is given to certain events, while others covered do not meet Wikipedia's criteria on notability. Could I please suggest:

  • The paragraph in relation to the proposed 2008 merger with United Business Media (UBM) is simplified.
  • Undue weight is given to mentioning alternative third-party attempts in acquiring Informa which are unconnected to talks with UBM.
  • Language surrounding talks ending due to an increase in share price, cited using an Independent article, is according to "sources close to UBM" so is not independently verifiable. The sentence referring to this should be removed.
  • Removal of the "Informaworld" discontinued domain paragraph.
  • It is not appropriate for inclusion within a "History" section, does not meet Wikipedia's criteria on notability and is supported by primary sources.
  • Removal of the sentence regarding Hobby Star Marketing.
  • The sentence is currently unreferenced, and while limited press does exist about the company's acquisition by Informa, it is not notable enough to warrant inclusion on the article.
  • Simplification of the paragraph regarding the acquisition of assets of Elsevier Business Intelligence (EBI) from Reed Elsevier to a single sentence.
  • Like the UBM paragraph, while the acquisition is somewhat notable, listing the various publications as part of the deal is undue weight.

In addition, indicated in bold, may a sentence be added:

  • Stating that Informa was redomiciled to the UK in 2014.
  • Providing background context to Stephen Carter’s appointment as CEO in first joining Informa as a non-executive director in 2010.

How it would appear:

Thanks all looking into my request. HisNamesJim (talk) 14:58, 17 October 2025 (UTC)

These changes look reasonable to me but I will let other editors comment. Dormskirk (talk) 15:07, 17 October 2025 (UTC)
Hi @Dormskirk and hope you have had a good weekend!
I appreciate that the site functions as a collaborative project, however, if these changes seem reasonable to you, could they be implemented? Aware that this request has been open for a month and this would help reduce the queue of pending COI requests, which has grown considerably over the past couple of weeks and might be getting overwhelming for the editors who regularly help out in that area. Thanks again! HisNamesJim (talk) 16:22, 10 November 2025 (UTC)
Now done. Dormskirk (talk) 16:35, 10 November 2025 (UTC)


History Section Request 3

edit

Thanks again @Dormskirk for implementing my last suggested changes.

My next request for the "History" section focuses on revising the first half of the "1998 to 2013" sub-section, focusing on events between 1998-2007.

Could I please suggest:

  • For the paragraph referring to business dealings involving Informa between 1998-2006 to be tidied. It currently:
  • Is hard to follow.
  • Uses incorrect tenses.
  • Includes tangential information i.e. the cost of acquiring IIR Holdings, Springer's share price offer to purchase Informa.
  • I have also added a new citation to support Informa's rejection of Springer's offer as the Forbes article leads to a dead link.
  • Removal of the paragraph about Richard Hooper's replacement by Peter Rigby.
  • The Forbes references which are used to cite this paragraph are dead links, and unavailable on the Wayback Machine. There is limited third-party press reporting on this change, which perhaps indicates it is does meet Wikipedia's notability criteria.
  • Additionally, I cannot find reliable and verified mention of these positional changes creating controversy with the UK's Combined Code on Corporate Governance, which may be synthesis by a historic editor.

How it would appear:

Thanks again for all looking into my request. HisNamesJim (talk) 17:33, 26 January 2026 (UTC)

Hi - I would prefer to retain the first sentence as it is as it seems to contain some important historical information about the background of the two companies. I am OK to substitute your sentence on Taylor & Francis and IRR. I am also content to trim the paragraph about the Springer bid. I would prefer to retain the first sentence about the change of management, but would be OK to drop the second sentence if other editors do not object. Dormskirk (talk) 18:29, 26 January 2026 (UTC)
Hi @Dormskirk and hope you have had a good start to the year. Your suggestions seem sensible to me.
Would you be happy to implement the changes in light of the continued backlog with the COI queue and lack of response here? Thanks for considering and for your feedback so far! HisNamesJim (talk) 16:29, 31 March 2026 (UTC)
Done. Dormskirk (talk) 17:17, 31 March 2026 (UTC)


History Section Request 4

edit

Hi there and thank you Dormskirk for reviewing my last request.

My next request involves revising the first half of the "2014 to present" subsection, covering the period 2014-2022.

  • Could I please suggest the addition of notable events including:
  • Informa's entry to the FTSE100 in 2016.
  • Well-publicised business dealings including acquisitions i.e. Penton in September 2016 and divestments i.e. the company's intelligence businesses in early 2022.
  • The company's response to the Covid pandemic.
  • The change in company chairman in June 2021.
  • I have also found three replacement citations for:
  • The Dove Medical Press acquisition,
  • The sale of UBM Life Sciences,
  • The launch of Omdia as the ones on the live article are broken links.
  • Removal of tangential information about the launch of Omdia.

How it would appear:

Thanks to those looking into my request! HisNamesJim (talk) 14:20, 1 April 2026 (UTC)

Looks OK to me but I will let other editors comment. Dormskirk (talk) 14:50, 1 April 2026 (UTC)
Hi Dormskirk and hope you are well.
Considering the continued backlog and lack of further input, would you feel comfortable actioning the changes? Thanks for considering and appreciate the time you always take to review my requests! HisNamesJim (talk) 12:15, 8 May 2026 (UTC)
Done. Dormskirk (talk) 14:35, 8 May 2026 (UTC)


History Section Request 5

edit

Hi there and thank you once again Dormskirk for your continued feedback.

My next request involves adding details related to notable acquisitions/partnerships covering the period 2022 to present. These cover:

  • Partnerships in Saudi Arabia and Dubai.
  • Acquisition of Winsight.

How it would appear:

Thanks for considering my request! HisNamesJim (talk) 16:09, 26 May 2026 (UTC)

Much of the above is unsourced and needs further work. Dormskirk (talk) 16:11, 26 May 2026 (UTC)
Hi Dormskirk and apologies for any misunderstanding.
I only added in the references for information which I was proposing to be added, however have now also added those on the existing "live" page. Thanks again for reviewing! HisNamesJim (talk) 16:22, 26 May 2026 (UTC)
That looks better, thanks. I will let others take a look. Dormskirk (talk) 16:34, 26 May 2026 (UTC)

Reply 20-JUN-2026

edit

🔼  H:WIKILINKs requested  

  1. Additional meaningfulness would be brought to the reader by having knowledge that these other associations—Tahaluf, Saudi Federation for Cybersecurity, Programming and Drones, Saudi Arabia's Events Investment Fund, Digital TV Europe, Television Business International and Dubai World Trade Center—are independently notable in Wikipedia. Without such knowledge, its inclusion here runs the risk of raising issues related to WP:COATRACK and WP:CHERRY.
  2. To assuage those concerns, kindly provide the H:WIKILINKs for Tahaluf, Saudi Federation for Cybersecurity, Programming and Drones, Saudi Arabia's Events Investment Fund, Digital TV Europe, Television Business International and Dubai World Trade Center.
  3. When ready to proceed with the requested information, kindly change the {{Edit COI}} template's answer parameter to read from |ans=y to |ans=n.

Regards,  Spintendo  19:02, 20 June 2026 (UTC)

Thanks for your input, and Wikilinks have been added. HisNamesJim (talk) 13:48, 24 June 2026 (UTC)
Hi Dormskirk and Spintendo. Hope both of you are well. Now that I've carried out the formatting changes, is this request now okay to be actioned? Thank you. HisNamesJim (talk) 09:07, 8 July 2026 (UTC)
OK with me if Spintendo is content. Dormskirk (talk) 09:21, 8 July 2026 (UTC)


Request to restore sourced expanded version and update obsolete information

edit

I disclose that I have a professional connection with the Instituto Superior de Ciências Policiais e Segurança Interna (ISCPSI).

On 10 May 2026, a substantially expanded and sourced version of this article was added. That version relied on public and verifiable sources, including the Diário da República, DGES, SIPA and official institutional sources. It corrected outdated information, including the current director, the legal status of the institute, its mission, courses and heraldry.

On 17 June 2026, that version was reverted with the edit summary “Rv AI”. I understand the concern, but the article content was based on cited public sources and was not intended as promotional material.

I request that an uninvolved editor review the sourced version at oldid=1353454135 and consider restoring it, either fully or section by section. At minimum, I request that the following outdated information be corrected:

  • Replace the obsolete image with File:ISCPSI logo 2026.png.
  • Replace “President Superintendente Abílio Pinto Vieira” with the current director, Chief Superintendent Luís Manuel Peça Farinha, supported by Despacho n.º 10152/2023.
  • Correct the establishment date and legal background using the cited Diário da República sources.
  • Restore the sourced sections on legal status, mission, police officer training, heraldry and director.

Thank you. David Gonçalo Barreiros dos Santos Gomes (talk) 10:21, 18 June 2026 (UTC)

Partly done: The infobox changes are restored. The sections that were removed can be seen in this diff if another editor wants to review Aloneinthewild (talk) 14:33, 27 June 2026 (UTC)


edit

I disclose again that I have a professional connection with the Instituto Superior de Ciências Policiais e Segurança Interna (ISCPSI). Following the partial implementation of the previous COI edit request, I would like to submit a narrower request concerning only the legal status and mission of the institute. I am not asking for the full expanded version to be restored at this stage. The current article is very short and does not explain the institute’s legal status or statutory mission. The proposed addition below is based on public and verifiable sources already used in the previous version of the article, especially Decree-Law No. 275/2009, of 2 October, Decree-Law No. 13/2022, of 12 January, and the Directorate-General for Higher Education registry. Suggested section to add after the lead:


Request: update "RunPod" styling to "Runpod" in portfolio list

edit

The portfolio section mentions "RunPod". The company changed its brand styling to "Runpod" (lowercase p), which is how its official site (https://www.runpod.io) and current independent coverage style it, e.g. the June 2026 financing coverage: "Runpod Raises $100M Led by Summit Partners" (https://www.prnewswire.com/news-releases/runpod-raises-100m-led-by-summit-partners-to-accelerate-the-ai-developer-cloud-302808689.html). Per MOS:TM (follow the styling used by current independent reliable sources), please update the visible mention to "Runpod". The existing 2024 reference and its title should stay as they are. Disclosure: I am a Runpod employee, per WP:PAID. Thank you. Dan.stotts (talk) 14:23, 9 July 2026 (UTC)


Proposal: add book to Further reading section

edit

Conflict of interest disclosure: I am the author of the book referenced below. Per Wikipedia:Conflict of interest, I am proposing this change here rather than editing the article directly. Proposed addition: I'd like to suggest adding the following to the "Further reading" section: * Nagasubramanian, Dhivya. Agentic AI for Engineers. Apress/Springer, 2026. ISBN 979-8-8688-2360-2. DOI: https://doi.org/10.1007/979-8-8688-2361-9 Why this is relevant: The book covers [topic — e.g., "agentic AI system design, intelligent agents,percieve-reason-act loop, safety, and enterprise deployment patterns"], which falls within the scope of this article. Independent evidence of notability/relevance: ["The book has been adopted in to 266 libraries across the country https://search.worldcat.org/title/1584648098 " I'd appreciate any feedback from editors on whether this addition is appropriate. Happy to adjust the citation format or wording as needed. Rine7986 (talk) 02:43, 20 June 2026 (UTC)


Edit Request

edit

I am an employee of Blumont and am submitting this request per Wikipedia's COI guidelines. I am not editing the article directly.

Issue: The information box on this page is outdated.

Current Text: • Founded: 1998 • Location: Washington DC, United States • Product: US government grantee and contractor • Key people: Arthur B Keys Jr (Founder), Roger Ervin (President)

Proposed Text: • Founded: 2016 (predecessor organization, International Relief and Development, founded 1998) • Location: Arlington, VA, United States • Product: International Development • Key people: Jonathan Nash, President & CEO (2020–present); Roger Ervin, President & CEO (2014–2019); Arthur B. Keys Jr., Founder & CEO, International Relief and Development (1998–2014)

Reason: Information in the info box is 10+ years old. Blumont was established in 2016 following a restructuring of International Relief and Development (IRD), which was founded in 1998. There have been changes in leadership and the organizations Blumont has worked with go beyond the U.S.government. Sources indicating/reflecting these changes are provided below.

Sources: Org Founding: “Blumont: The new face of IRD.” Devex. January 22, 2016. Accessed March 25, 2026. Leadership:“Interrupted relief: Politics, reform, and the uncertain future of USAID.” The Harvard Independent. April 3, 2025. Retrieved March 30, 2026. “Jonathan Nash on MCC’s evolution from ‘bold experiment’ to data-driven agency.” Devex. February 14, 2019. Retrieved March 25, 2026. “Blumont: The new face of IRD.” Devex. January 22, 2016. Accessed March 25, 2026. “Doing well by doing good: The high price of working in war zones.” The Washington Post. May 4, 2014. Retrieved March 25, 2026. Product/Type of Work: “UNHCR, Blumont join hands to foster sustainable local economic development.” The Jordan Times. June 15, 2022. Retrieved March 26, 2026 “USAID chooses 11 for $5B global stability support recompete.” Washington Technology. September 4, 2024. Retrieved March 26, 2026.

I appreciate consideration and implementation of these changes if found appropriate. Thank you. UmmmK (talk) 15:47, 30 March 2026 (UTC)

Partly done – I updated the infobox with current information. I did not change the founding date, because Blumont's website describes the organization as having "more than two decades of experience," which suggests it's a continuation of RD rather than a wholly new organization founded in 2016. ◦ Sibshops (talk) 16:29, 30 March 2026 (UTC)
Thank you. I appreciate your review and the updates. UmmmK (talk) 16:55, 30 March 2026 (UTC)


Proposed Structural and Content Updates (COI Disclosure)

edit

Hello Editors,

I am writing to request a review of a proposed rewrite of this article. I want to be upfront: I am an employee of Blumont (formerly International Relief and Development) and have a Conflict of Interest (COI). In keeping with Wikipedia's COI guidelines, I have not and will not edit the article directly. Instead, I developed a fully updated and cited draft in my sandbox and am requesting that independent editors review it and, if appropriate, implement changes.

Thank you for your time and consideration. UmmmK (talk) 14:59, 11 May 2026 (UTC)

Reply 14-JUN-2026

edit

  Edit request declined  

  • The information concerning the Washington Post investigation has not only been removed from the lead, it has been broken up scattered across several subsections within the history section. I was hard pressed to find any of it. The thing which I had no diffculty in finding was the continued reference to the founder as "Dr." in contravention to MOS:DOCTOR. The more it changes, the more it's the same thing I suppose.
  • I agree that the article ought not to be a large referendum on the WP investigation. But this compromise draft breaks up that investigation and scatters it like a carcass across several sections, presumably, so no one could find it. This is not the ideal response.
  • Another issue is when multipage reports are used as a reference without page numbers. It's as if the reader is expected to read 93 pages to confirm one fact. There needs to be a greater delineation with respect to the use of {{cite report}}.
  • Suggestion: At a minimum, there must be one, perhaps two sentences in the lead section mentioning the WP investigation. That investigation arguably led us down the road towards Blumont. The article avoids that fact at its own peril. Page numbers need to be used when any multipage file is linked to, and used as a source in the article. If the document has several instances of use with different page numbers at each use, you can use the {{rp}} template to add the page numbers so that they display inline. And Dr. Arthur Keys needs to be referred to as Arthur Keys, or simply Keys, with each subsequent mention.

Regards,  Spintendo  08:02, 14 June 2026 (UTC)

Thank you for the review and feedback. I updated the sandbox draft to address the points you highlighted:
MOS:DOCTOR: "Dr." has been removed from all references to Arthur Keys throughout the draft.
Page citations: Specific page numbers have been added inline using {{rp}} for all multi-page government reports (references 5 and 6). The page ranges remain in the citation entries as well.
On the lead section: As noted in my original submission, the sandbox draft intentionally does not include a revised lead, as the lead should summarize the article body once that content has been reviewed and agreed upon. This is consistent with standard Wikipedia practice, and the Washington Post investigation and USAID suspension are covered in full in the Investigations section.
Regards, UmmmK (talk) 17:26, 22 June 2026 (UTC)


Edit Request: Updated Draft (COI Disclosed)

edit

A prior review raised concerns about citation formatting and the MOS:DOCTOR honorific guideline. Those issues have been addressed in an updated draft. A summary of changes is in the thread above from May 2026.

The draft does not include a revised lead section, as the lead should reflect the article body once content has been reviewed and agreed upon.

The updated draft is at User:UmmmK/sandbox. I welcome and appreciate review.

UmmmK (talk) 18:53, 10 July 2026 (UTC)


Previous page Next page